Biotechnology

(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company presented fo...

2020-05-31 20:00 2286

I-Mab Announces Upcoming Participation at June Conferences

SHANGHAI and GAITHERSBURG, Md., May 29, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical ...

2020-05-29 20:00 6156

Seaweed Extract Offers Hope for Influenza A

CAMBRIDGE, Australia, May 28, 2020 /PRNewswire/ --  Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A. Fucoidan is a highly bioactive compound found naturally in brown seaweed and well known for its diverse therapeu...

2020-05-28 15:30 1172

IntegriCulture Inc. Closes Series A Fundraising Round Led by Beyond Next Ventures at JPY800 Million

TOKYO, May 28, 2020 /PRNewswire/ -- IntegriCulture Inc. has completed a Series A fundraising round ofJPY800 million (USD7.4 million) backed by Beyond Next Ventures, NH Foods, AgFunder and other investors. The cumulative amount raised stands aboutJPY1.1 billion (USD10.2 million). (Logo: https://...

2020-05-28 13:00 2134

Transcenta Presents First Data from Phase 1 Study of pH-Dependent PDL1 Antibody MSB2311 in Patients with Pre-treated Advanced Solid Tumors and Select Hematological Malignancies

SUZHOU, China, May 27, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery,development and manufacturing of antibody-based therapeutics, announced today results reported for the first time from a Phase 1...

2020-05-27 23:00 1225

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

AMBLER, Pa., May 25, 2020 /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab's Du...

2020-05-25 22:00 1548

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. Under the terms of th...

2020-05-22 07:11 6451

Transcenta Announces to Present Preclinical Data of TST001 at 2020 AACR Virtual Annual Meeting II

SUZHOU, China, May 21, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing, today announced that it will present preclinical data of TST001, a humanized Claudin 18.2 (CLDN18.2) monoclonal ...

2020-05-21 23:00 1603

China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan"), China Biolog...

2020-05-21 04:45 11480

China Biologic Reports Financial Results for the First Quarter of 2020

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the first quarter of 2020. First Quarter ...

2020-05-21 04:30 10670

VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 20, 2020 /PRNewswire/ -- VolitionRx Limited  (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to hel...

2020-05-20 20:45 10867

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced today the expansion of its service capabilities to offer a fully int...

2020-05-18 21:00 1978

I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service

PALO ALTO, Calif., May 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up focusing on Nobel Prize-wining technology "induced pluripotent stem cell (iPSC)" began manufacturing clinical-grade iPSCs. We are now officially taking orders for custom manufacturi...

2020-05-16 01:00 2657

Happiness Biotech Announced Innovative Cultivation Technology of Lucidum

NANPING, China, May 13, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has successfully developed an innovative cultivation technology of lucidum, which...

2020-05-13 20:00 4624

China Biologic Products to Report First Quarter 2020 Financial Results

BEIJING, China, May 12, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its first quarter 2020 financial res...

2020-05-12 20:30 9674

BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing

SHENZHEN, China, May 11, 2020 /PRNewswire/ -- BGI Genomics announced that its Real-time fluorescent RT-PCR kit for detecting 2019-nCoV has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process.  The EUL is a risk-based procedure...

2020-05-12 02:00 4593

Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forward

SAN DIEGO, May 11, 2020 /PRNewswire/ -- Singlera Genomics completed their second Pre-Submission Meeting with the US FDA Center for Devices and Radiological Health, Office of In Vitro Diagnostics onApril 21, 2020, after an initial Pre-Submission Meeting in the fall of 2019. The FDA provided clear ...

2020-05-12 01:39 1354

Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings

BOSTON and WUHAN, China, May 11, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing innovative therapies for ocular and other genetic disease, today announced that the results of two clinical studies utilizing NFS-01 (rAAV2-ND4) in...

2020-05-11 20:00 1553

Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension

SINGAPORE, May 10, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company focused on the discovery and development of new breakthrough therapies, has closed an extended Series B funding round ofUS$25 million. This brings the total capital raised through financing activ...

2020-05-11 08:00 1617

HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance

HANGZHOU, China, May 8, 2020 /PRNewswire/ -- HJB, a biologics CDMO committed to quality, reliability and speed for each and every CMCpackage delivered to its partners, today announces that its partner Mabspace Biosciences has received Investigational New Drug (IND) clearance from both the U.S. Fo...

2020-05-08 23:00 1924
1 ... 119120121122123124125 ... 127